Preclinical Validation of Repurposable Candidate Drug Compound for Cystic Nephropathies

Clanget, T.; Heigwer, J.; Pandey, G.; Kraft, P.; Rodenbeck, B.; Mayer, T.; Tabatabaeifar, M.; Gehrig, J.; Westhoff, J.; Korkmaz-Icöz, S.; Schaefer, F.
Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_6189 (2023)

Early-onset cystic kidney disease is a clinically and genetically heterogeneous and overlapping group of rare and often severe disorders with limited, mostly symptomatic treatment options. We developed and utilized inherited polycystic cystic kidney disease (PKD) models to search for pharmacological agents that can rescue or mitigate the disease phenotype.

More info at :